相关实验视频
Updated: Jun 28, 2025

09:36
Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
329
基化BET原蛋白抑制剂同样针对小岛内分泌细胞类型
Rachel A Jones Lipinski1,2, Jennifer S Stancill1, Raymundo Nuñez1
1Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
概括
研究人员探索了针对特定细胞的糖尿病治疗方法,使用一种新型的原体和外端域抑制剂 (BETi). 虽然没有达到β细胞选择性,但该研究揭示了对内分泌细胞向和糖尿病治疗潜在的巨细胞向策略的洞察力.
科学领域:
- 生物化学和分子生物学
- 内分泌学和新陈代谢学
- 药物发现和开发 药物发现和开发
背景情况:
- 和外端域 (BET) 蛋白家族抑制是糖尿病预防和治疗的一个有前途的策略.
- 由于不良影响,BET代酶抑制剂 (BETis) 的临床应用受到限制.
- 将BETis向特定的细胞,如胰腺β细胞,可以减轻副作用.
研究的目的:
- 开发一种针对BET抑制剂选择性向胰腺β细胞的策略.
- 为了利用β细胞中的高细胞内 (Zn2+) 度用于药物积累.
- 合成和评估一种新的Zn2+化BET抑制剂衍生物.
主要方法:
- 一种新型Zn2+化BET抑制剂, (+) -JQ1-DPA和控制化合物的合成.
- 分子建模和生物物理测试以确认与BET原体的结合亲和力.
- 在β细胞和小岛细胞类型 (α细胞,巨细胞) 中进行细胞检测,以评估选择性和疗效.
主要成果:
- 合成的化合物 (+) - JQ1-DPA和 (+) - JQ1-DBA保留了强大的结合 BET 原体.
- (+) -JQ1-DPA在β细胞和α细胞中显示出有效性,但在巨细胞中效果较差,表明内分泌细胞选择性,而不是β细胞特异性.
- 非化衍生物 (+) -JQ1-DBA在巨细胞中显示出更大的疗效,这表明巨细胞向治疗的潜力.
结论:
- 2+化小分子对胰腺内分泌细胞具有选择性,而不是仅限于β细胞.
- 这项研究为评估Zn2+化作为选择性小分子向策略提供了有价值的见解和技术.
- 研究结果表明,通过调节特定岛屿细胞群或免疫细胞中的BET蛋白活性,有可能开发针对糖尿病的向疗法.
相关概念视频
Glucagon-like Receptor Agonists
319
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
319
Dipeptidyl Peptidase 4 Inhibitors
182
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
182
Insulin: Biosynthesis, Chemistry, and Preparation
374
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
374
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Oral Hypoglycemic Agents: Biguanides and Glitazones
195
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
195
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K

